This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Aventis Pharmaceuticals Inc., Libramen Naturals Inc., Other. Active years: 1998-2019.
Location History:
- Hamilton, CA (2005)
- Hamilton, CA (US) (2007)
- Ontario, CA (1998 - 2019)
Company Filing History:
4 out of 207 
2 out of 2 
2 out of 834,411 Years Active: 1998-2019
Title: Michel P Rathbone: Innovator in G-Protein Coupled Receptor Research
Introduction
Michel P Rathbone is a notable inventor based in California, recognized for his contributions to the field of biochemistry and molecular biology. He holds a total of 8 patents, showcasing his innovative work in developing transformed cell lines for research purposes.
Latest Patents
Rathbone's latest patents focus on transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors. These patents disclose techniques for transforming Drosophila Schneider 2 cells and human astrocytoma 1321N1 cells to express G-Protein Coupled Receptor GPCR22. The transformed cell lines are instrumental in identifying guanosine analogues and functional equivalents, which can have significant implications in drug discovery and development.
Career Highlights
Throughout his career, Rathbone has worked with prominent organizations, including Aventis Pharmaceuticals Inc. His work has significantly advanced the understanding of G-protein coupled receptors and their applications in pharmacology.
Collaborations
Rathbone has collaborated with notable colleagues such as Craig P Smith and Margaret Petty, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Michel P Rathbone's work in the development of transformed cell lines and G-protein coupled receptors has made a lasting impact on biochemistry and pharmacology. His innovative spirit continues to drive advancements in the identification of new therapeutic compounds.